Cubist Systematic Strategies’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Cubist Systematic Strategies’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-32,565	Closed	-$334K	–	4208
2023 Q2	$334K	Sell	32,565 -42,805	-57%	-$437K	﹤0.01%	2587
2023 Q1	$763K	Sell	75,370 -364,784	-83%	-$3.67M	﹤0.01%	2399
2022 Q4	$4.4M	Sell	440,154 -5,256	-1%	-$51.7K	0.03%	1135
2022 Q3	$4.33M	Buy	445,410 +304,492	+216%	+$2.96M	0.02%	1222
2022 Q2	$1.36M	Buy	+140,918	New	+$1.37M	0.01%	2203
2022 Q1	–	Sell	-2,247	Closed	-$22K	–	3902
2021 Q4	$22K	Buy	+2,247	New	+$22K	﹤0.01%	3371

Cubist Systematic Strategies's DALS Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 32,565 shares — an estimated $334K sold.

Cubist Systematic Strategies first reported a position in DALS in Q4 2021 and held it in 6 quarters. The position peaked at $4.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Cubist Systematic Strategies reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 32,565 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $334K.
Cubist Systematic Strategies first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Cubist Systematic Strategies's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $4.4M in Q4 2022.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.